Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy
PI-RADSv2.1 using mpMRI and bpMRI could stratify the risk of csPCa, and the csPCa detection rate of bpMRI was compatible with that of mpMRI using cut-offs of PI-RADSv2.1 categories ≥ 3 or ≥ 4.
Authors
- Koichiro Kimura (ORCID: https://orcid.org/0000-0003-3190-8508)
- Ukihide Tateishi (ORCID: https://orcid.org/0000-0002-6548-8698)
- Soichiro Yoshida (ORCID: https://orcid.org/0000-0003-2757-8083)
- Naohiro Yamaya
- Junichi Tsuchiya (ORCID: https://orcid.org/0000-0001-8392-2227)
- Ryota Ichikawa
- Yasuhisa Fujii (ORCID: https://orcid.org/0000-0002-6761-3229)
- Masaki Kobayashi (ORCID: https://orcid.org/0000-0003-2738-9792)
- Kenichi Fukui (ORCID: https://orcid.org/0000-0001-8780-5853)
- Yusuke Kawasaki
- M Kawanishi
- S. Higuchi
Institutions
- Tokyo Medical and Dental University (JP)
- Kameda Medical Center (JP)
- JA Toride Medical Center (JP)
- The Cancer Institute Hospital (JP)
- Asahi General Hospital (JP)
- Soka Municipal Hospital (JP)
Publication Details
- Journal
- Japanese Journal of Radiology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1007/s11604-024-01675-4
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26